Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Letter: Levamisole

J Symoens

    Lancet (London, England)
    |April 12, 1975
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Vascular Protection by Ketanserin, a 5-HT(2) Serotonergic Receptor Antagonist?

    Platelets·2010
    Same author

    Ketanserin in the treatment of peripheral vascular disease or hypertension in patients with diabetes mellitus: a review.

    Journal of cardiovascular pharmacology·1991
    Same author

    Ketanserin: a novel cardiovascular drug.

    Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis·1990
    Same author

    [Clinical profile of a new antihypertensive agents. Ketanserin].

    Revue medicale de Liege·1988
    Same author

    Ketanserin and QTc prolongation.

    European heart journal·1987
    Same author

    Ketanserin compared to nifedipine and methyldopa in patients aged above 50 years: two international multicentre studies. For the International Study Group.

    Journal of hypertension. Supplement : official journal of the International Society of Hypertension·1986
    Same journal

    Rethinking anticoagulation intensity during extracorporeal membrane oxygenation.

    Lancet (London, England)·2026
    Same journal

    Standard-dose unfractionated heparin versus low-dose unfractionated heparin and low-molecular-weight heparin in extracorporeal life support (RATE): an open-label, randomised, non-inferiority trial.

    Lancet (London, England)·2026
    Same journal

    Inherited retinal degenerations: clinical phenotypes and emerging therapies.

    Lancet (London, England)·2026
    Same journal

    Documenting hospice care.

    Lancet (London, England)·2026
    Same journal

    After the wood chipper.

    Lancet (London, England)·2026
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    See all related articles